Source: FinanzNachrichten

CV Sciences: CV Sciences, Inc. To Announce Year End and Fourth Quarter 2024 Results On March 27, 2025

SAN DIEGO, CALIFORNIA / ACCESS Newswire / March 20, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in...

Read full article »
Annual Revenue
$5.0-25M
Employees
25-100
Joseph Dowling's photo - CEO of CV Sciences

CEO

Joseph Dowling

CEO Approval Rating

86/100

Read more